<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Drug Company Denies Harvard Rheumatoid Arthritis Researcher</title><link>http://articles.mercola.com/sites/articles/archive/2002/07/13/ra-researcher.aspx</link><description>By Alice Dembner Dr. David Trentham is the chairman of the Department of Rheumatology at Harvard. He has used the antibiotic Minocin for successfully for many with rheumatoid arthritis and scleroderma. He decided to study the drug in those ages 6 to 14</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>